RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
US Neurosurgical Holdings - Stock

US Neurosurgical Holdings Revenue 2024

US Neurosurgical Holdings Revenue

0 USD

Ticker

USNU

ISIN

US90336K1016

In 2024, US Neurosurgical Holdings's sales reached 0 USD, a 0% difference from the 1.06 M USD sales recorded in the previous year.

The US Neurosurgical Holdings Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2022--
20211.0691,89
20203.1788,62
20193.0788,60
20183.4260,84
20173.4157,03
20163.2159,84
20152.9759,78
20142.6173,46

US Neurosurgical Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into US Neurosurgical Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by US Neurosurgical Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects US Neurosurgical Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of US Neurosurgical Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into US Neurosurgical Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing US Neurosurgical Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on US Neurosurgical Holdings’s growth potential.

US Neurosurgical Holdings Revenue, EBIT and net profit per share

DateUS Neurosurgical Holdings RevenueUS Neurosurgical Holdings EBITUS Neurosurgical Holdings Net Income
20220 undefined-1.39 M undefined-1.34 M undefined
20211.06 M undefined-88,000 undefined-881,000 undefined
20203.17 M undefined1.62 M undefined533,000 undefined
20193.07 M undefined1.49 M undefined142,000 undefined
20183.42 M undefined794,000 undefined-421,000 undefined
20173.41 M undefined688,000 undefined538,000 undefined
20163.21 M undefined614,000 undefined536,000 undefined
20152.97 M undefined544,000 undefined396,000 undefined
20142.61 M undefined736,000 undefined561,000 undefined

US Neurosurgical Holdings stock margins

The US Neurosurgical Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of US Neurosurgical Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for US Neurosurgical Holdings.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the US Neurosurgical Holdings's sales revenue. A higher gross margin percentage indicates that the US Neurosurgical Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the US Neurosurgical Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the US Neurosurgical Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the US Neurosurgical Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the US Neurosurgical Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the US Neurosurgical Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

US Neurosurgical Holdings Margin History

US Neurosurgical Holdings Gross marginUS Neurosurgical Holdings Profit marginUS Neurosurgical Holdings EBIT marginUS Neurosurgical Holdings Profit margin
202291.89 %0 %0 %
202191.89 %-8.29 %-83.03 %
202088.62 %50.9 %16.8 %
201988.6 %48.53 %4.63 %
201860.84 %23.19 %-12.3 %
201757.03 %20.15 %15.76 %
201659.84 %19.12 %16.69 %
201559.78 %18.31 %13.33 %
201473.46 %28.23 %21.52 %

US Neurosurgical Holdings Aktienanalyse

What does US Neurosurgical Holdings do?

US Neurosurgical Holdings Inc (USN) is a diversified medical company that specializes in the development and marketing of innovative neurosurgical instruments and devices to improve patient care. History: The company's history dates back to 1996 when USN was founded to meet market needs in neurosurgical device supply. With a focus on quality, innovation, and customer satisfaction, USN became a pioneer in neurosurgical instruments and devices. Business model: USN's business model focuses on the manufacturing and marketing of products and services in the field of neurosurgical devices and instruments. The company aims to meet the needs of customers in this area and build long-term partnerships with them. The company works directly with customers such as neurosurgeons, hospitals, medical facilities, and healthcare institutions to ensure effective delivery of products and services. Divisions: USN operates multiple business divisions tailored to the needs of the healthcare sector. These include: 1. Neurosurgical instruments: USN offers a wide range of neurosurgical instruments that can be used for diagnostic or therapeutic work. The products include specialized microscopes, standard and custom instruments, as well as devices for spinal or brain surgery. The instruments are made of high-quality materials and meet the highest quality standards. 2. Neurodiagnostic equipment: Neurological examinations are essential for achieving good results. USN has a variety of biomedical devices used in this field, such as measurement probes, EEG equipment, IT systems, patient monitoring solutions, etc. 3. Neuro-implants: USN also offers a range of implants that can be used to treat various neurological impairments. These include ventriculoperitoneal shunts or hair-like implants. Products: USN offers a wide range of products, including: 1. Neurosurgical instruments: The company offers various types of neurosurgical instruments, including microscopes, standard and custom instruments. Popular products include standard and custom instrument sets used to support neurosurgical procedures. These sets are developed in close collaboration with neurosurgeons and other healthcare providers. 2. Neurodiagnostic equipment: USN offers a wide range of neurodiagnostic products, such as measurement probes, EEG equipment, IT systems, patient monitoring solutions, which can be used in various areas of the healthcare sector. 3. Neuro-implants: USN also offers a range of implants, including ventriculoperitoneal shunts for treating normal pressure hydrocephalus or implants that mimic the shape of hair. These implants are used to treat various neurological disorders. Conclusion: US Neurosurgical Holdings is a pioneer in neurosurgical device supply and has established itself as a significant industry leader. With a wide range of products and services, the company is well-positioned to meet the needs of customers in the healthcare sector. USN's focus on quality and customer satisfaction has made it the choice for many healthcare providers in need of state-of-the-art neurosurgical devices and instruments. US Neurosurgical Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding US Neurosurgical Holdings's Sales Figures

The sales figures of US Neurosurgical Holdings originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing US Neurosurgical Holdings’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize US Neurosurgical Holdings's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in US Neurosurgical Holdings’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about US Neurosurgical Holdings Stock

How much revenue did US Neurosurgical Holdings generate this year?

US Neurosurgical Holdings has achieved a revenue of 0 USD this year.

How much was the turnover of the company US Neurosurgical Holdings compared to the previous year?

The revenue of US Neurosurgical Holdings has increased by 0% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of US Neurosurgical Holdings?

The revenue of US Neurosurgical Holdings is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of US Neurosurgical Holdings measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of US Neurosurgical Holdings so important for investors?

The revenue of US Neurosurgical Holdings is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does US Neurosurgical Holdings pay?

Over the past 12 months, US Neurosurgical Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, US Neurosurgical Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of US Neurosurgical Holdings?

The current dividend yield of US Neurosurgical Holdings is .

When does US Neurosurgical Holdings pay dividends?

US Neurosurgical Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of US Neurosurgical Holdings?

US Neurosurgical Holdings paid dividends every year for the past 0 years.

What is the dividend of US Neurosurgical Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is US Neurosurgical Holdings located?

US Neurosurgical Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von US Neurosurgical Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of US Neurosurgical Holdings from 7/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/2/2024.

When did US Neurosurgical Holdings pay the last dividend?

The last dividend was paid out on 7/2/2024.

What was the dividend of US Neurosurgical Holdings in the year 2023?

In the year 2023, US Neurosurgical Holdings distributed 0 USD as dividends.

In which currency does US Neurosurgical Holdings pay out the dividend?

The dividends of US Neurosurgical Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von US Neurosurgical Holdings

Our stock analysis for US Neurosurgical Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of US Neurosurgical Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.